Liposomal Bupivacaine

Pain after total joint arthroplasty (TJA) can be severe and difficult to control. A single-dose local analgesic delivers bupivacaine in a liposomal time-release platform. In 2248 consecutive patients with hip and knee arthroplasty, half (Pre) were treated using a well-established multimodal analgesia, including periarticular injection (PAI), and half had the PAI substituted for a liposomal bupivacaine injection technique (Post). Pain scores were significantly lower for patients in the Post group for both hip and knee procedures. A large series of patients who had TJA experienced pain relief after the introduction of liposomal bupivacaine as part of an established multimodal protocol.

  • We found improvement in pain relief in a large series of patients who had TJA after the introduction of a liposomal bupivacaine as part of an established multimodal protocol.

  • We found improvement in pain relief in a large series of patients who had TJA after the introduction of a liposomal bupivacaine as part of an established multimodal protocol.

  • References

    1. 1. Hall M.J., DeFrances C.J., Williams S.N., et al: National Hospital Discharge Survey: 2007 summary. Natl Health Stat Report 2010; undefined: pp. 1-20

    2. 2. Ethgen O., Bruyere O., Richy F., et al: Health-related quality of life in total hip and total knee arthroplasty. A qualitative and systematic review of the literature. J Bone Joint Surg Am 2004; 86A: pp. 963-974

    3. 3. Affas F., Nygards E.B., Stiller C.O., et al: Pain control after total knee arthroplasty: a randomized trial comparing local infiltration anesthesia and continuous femoral block. Acta Orthop 2011; 82: pp. 441-447

    4. 4. Morrison R.S., Magaziner J., McLaughlin M.A., et al: The impact of post-operative pain on outcomes following hip fracture. Pain 2003; 103: pp. 303-311

    5. 5. Dihle A., Helseth S., Kongsgaard U.E., et al: Using the American Pain Society’s patient outcome questionnaire to evaluate the quality of postoperative pain management in a sample of Norwegian patients. J Pain 2006; 7: pp. 272-280

    6. 6. Dihle A., Helseth S., Paul S.M., et al: The exploration of the establishment of cutpoints to categorize the severity of acute postoperative pain. Clin J pain 2006; 22: pp. 617-624

    7. 7. Kehlet H., Jensen T.S., and Woolf C.J.: Persistent postsurgical pain: risk factors and prevention. Lancet 2006; 367: pp. 1618-1625

    8. 8. Perkins F.M., and Kehlet H.: Chronic pain as an outcome of surgery. A review of predictive factors. Anesthesiology 2000; 93: pp. 1123-1133

    9. 9. Kessler E.R., Shah M., Gruschkus S.K., et al: Cost and quality implications of opioid-based postsurgical pain control using administrative claims data from a large health system: opioid-related adverse events and their impact on clinical and economic outcomes. Pharmacotherapy 2013; 33: pp. 383-391

    10. 10. Coley K.C., Williams B.A., DaPos S.V., et al: Retrospective evaluation of unanticipated admissions and readmissions after same day surgery and associated costs. J Clin Anesth 2002; 14: pp. 349-353

    11. 11. Azim S.A., Sangster R., Curcio C., et al: Characterization of patients with difficult-to-treat acute pain following total knee arthroplasty using multi-modal analgesia. Open Pain J 2013; 6: pp. 1-6

    12. 12. Pogatzki-Zahn E.M., Schnabel A., and Zahn P.K.: Room for improvement: unmet needs in postoperative pain management. Expert Rev Neurother 2012; 12: pp. 587-600

    13. 13. Holzer P.: Opioid receptors in the gastrointestinal tract. Regul Pept 2009; 155: pp. 11-17

    14. 14. Oderda G.M., Evans R.S., Lloyd J., et al: Cost of opioid-related adverse drug events in surgical patients. J Pain Symptom Manage 2003; 25: pp. 276-283

    15. 15. Wheeler M., Oderda G.M., Ashburn M.A., et al: Adverse events associated with postoperative opioid analgesia: a systematic review. J Pain 2002; 3: pp. 159-180

    16. 16. Oderda G.M., Said Q., Evans R.S., et al: Opioid-related adverse drug events in surgical hospitalizations: impact on costs and length of stay. Ann Pharmacother 2007; 41: pp. 400-406

    17. 17. Cepeda M.S., Farrar J.T., Baumgarten M., et al: Side effects of opioids during short-term administration: effect of age, gender, and race. Clin Pharmacol Ther 2003; 74: pp. 102-112

    18. 18. Sharma S., Iorio R., Specht L.M., et al: Complications of femoral nerve block for total knee arthroplasty. Clin Orthop Relat Res 2010; 468: pp. 135-140

    19. 19. Beaupre L.A., Johnston D.B., Dieleman S., et al: Impact of a preemptive multimodal analgesia plus femoral nerve blockade protocol on rehabilitation, hospital length of stay, and postoperative analgesia after primary total knee arthroplasty: a controlled clinical pilot study. ScientificWorldJournal 2012; 2012: pp. 273821

    20. 20. Kerr D.R., and Kohan L.: Local infiltration analgesia: a technique for the control of acute postoperative pain following knee and hip surgery: a case study of 325 patients. Acta Orthop 2008; 79: pp. 174-183

    21. 21. Parvataneni H.K., Shah V.P., Howard H., et al: Controlling pain after total hip and knee arthroplasty using a multimodal protocol with local periarticular injections: a prospective randomized study. J Arthroplasty 2007; 22: pp. 33-38

    22. 22. Busch C.A., Shore B.J., Bhandari R., et al: Efficacy of periarticular multimodal drug injection in total knee arthroplasty. A randomized trial. J Bone Joint Surg Am 2006; 88: pp. 959-963

    23. 23. Paul J.E., Arya A., Hurlburt L., et al: Femoral nerve block improves analgesia outcomes after total knee arthroplasty: a meta-analysis of randomized controlled trials. Anesthesiology 2010; 113: pp. 1144-1162

    24. 24. Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management. Anesthesiology 2012; 116: pp. 248-273

    25. 25. Kehlet H.: Surgical stress: the role of pain and analgesia. Br J Anaesth 1989; 63: pp. 189-195

    26. 26. Pavlin D.J., Chen C., Penaloza D.A., et al: A survey of pain and other symptoms that affect the recovery process after discharge from an ambulatory surgery unit. J Clin Anesth 2004; 16: pp. 200-206

    27. 27. Wu C.L., Naqibuddin M., Rowlingson A.J., et al: The effect of pain on health-related quality of life in the immediate postoperative period. Anesth Analg 2003; 97: pp. 1078-1085

    28. 28. Carr D.B., Reines H.D., Schaffer J., et al: The impact of technology on the analgesic gap and quality of acute pain management. Reg Anesth Pain Med 2005; 30: pp. 286-291

    29. 29. Ng A., Hall F., Atkinson A., et al: Bridging the analgesic gap. Acute Pain 2000; 3: pp. 1-6

    30. 30. Chen P.P., Chui P.T., Ma M., et al: A prospective survey of patients after cessation of patient-controlled analgesia. Anesth Analg 2001; 92: pp. 224-227

    31. 31. Green C.R., Anderson K.O., Baker T.A., et al: The unequal burden of pain: confronting racial and ethnic disparities in pain. Pain Med 2003; 4: pp. 277-294

    32. 32. Atherton M.J., Feeg V.D., and el-Adham A.F.: Race, ethnicity, and insurance as determinants of epidural use: analysis of a national sample survey. Nurs Econ 2004; 22: pp. 6-13

    33. 33. Joshi G.P., and Kehlet H.: Procedure-specific pain management: the road to improve postsurgical pain management? Anesthesiology 2013; 118: pp. 780-782

    34. 34. Davidson E.M., Barenholz Y., Cohen R., et al: High-dose bupivacaine remotely loaded into multivesicular liposomes demonstrates slow drug release without systemic toxic plasma concentrations after subcutaneous administration in humans. Anesth Analg 2010; 110: pp. 1018-1023

    35. 35. Bergese S.D., Ramamoorthy S., Patou G., et al: Efficacy profile of liposome bupivacaine, a novel formulation of bupivacaine for postsurgical analgesia. J Pain Res 2012; 5: pp. 107-116

    36. 36. Dasta J., Ramamoorthy S., Patou G., et al: Bupivacaine liposome injectable suspension compared with bupivacaine HCl for the reduction of opioid burden in the postsurgical setting. Curr Med Res Opin 2012; 28: pp. 1609-1615

    37. 37. Golf M., Daniels S.E., and Onel E.: A phase 3, randomized, placebo-controlled trial of DepoFoam® bupivacaine (extended-release bupivacaine local analgesic) in bunionectomy. Adv Ther 2011; 28: pp. 776-788

    38. 38. Cohen S.M.: Extended pain relief trial utilizing infiltration of Exparel(®), a long-acting multivesicular liposome formulation of bupivacaine: a phase IV health economic trial in adult patients undergoing open colectomy. J Pain Res 2012; 5: pp. 567-572

    39. 39. Marcet J.E., Nfonsam V.N., and Larach S.: An extended paIn relief trial utilizing the infiltration of a long-acting Multivesicular liposome formulation of bupivacaine, EXPAREL (IMPROVE): a Phase IV health economic trial in adult patients undergoing ileostomy reversal. J Pain Res 2013; 6: pp. 549-555

    40. 40. Vogel J.D.: Liposome bupivacaine (EXPAREL®) for extended pain relief in patients undergoing ileostomy reversal at a single institution with a fast-track discharge protocol: an IMPROVE Phase IV health economics trial. J Pain Res 2013; 6: pp. 605-610

    41. 41. Haas E., Onel E., Miller H., et al: A double-blind, randomized, active-controlled study for post-hemorrhoidectomy pain management with liposome bupivacaine, a novel local analgesic formulation. Am Surg 2012; 78: pp. 574-581

    42. 42. Bergese S.D., Onel E., Morren M., et al: Bupivacaine extended-release liposome injection exhibits a favorable cardiac safety profile. Reg Anesth Pain Med 2012; 37: pp. 145-151

    43. 43. Syed H.M., Green L., Bianski B., et al: Bupivacaine and triamcinolone may be toxic to human chondrocytes: a pilot study. Clin Orthop Relat Res 2011; 469: pp. 2941-2947

    44. 44. Richman J.M., Liu S.S., Courpas G., et al: Does continuous peripheral nerve block provide superior pain control to opioids? A meta-analysis. Anesth Analg 2006; 102: pp. 248-257

    45. 45. Capdevila X., Barthelet Y., Biboulet P., et al: Effects of perioperative analgesic technique on the surgical outcome and duration of rehabilitation after major knee surgery. Anesthesiology 1999; 91: pp. 8-15

    46. 46. Nuelle D.G., and Mann K.: Minimal incision protocols for anesthesia, pain management, and physical therapy with standard incisions in hip and knee arthroplasties: the effect on early outcomes. J Arthroplasty 2007; 22: pp. 20-25

    47. 47. Committee on Advancing Pain Research, Care, and Education. Relieving pain in America: a blueprint for transforming prevention, care, education, and research. Washington, DC: Institute of Medicine of the National Academies. 2011.

    48. 48. Southworth S., Peters J., Rock A., et al: A multicenter, randomized, double-blind, placebo-controlled trial of intravenous ibuprofen 400 and 800 mg every 6 hours in the management of postoperative pain. Clin Ther 2009; 31: pp. 1922-1935

    49. 49. Sinatra R.S., Jahr J.S., Reynolds L.W., et al: Efficacy and safety of single and repeated administration of 1 gram intravenous acetaminophen injection (paracetamol) for pain management after major orthopedic surgery. Anesthesiology 2005; 102: pp. 822-831

    50. 50. US Department of Health and Human Services CfMaM. HCAHPS: Patients’ Perspectives of Care Survey. Avialable online at:

    51. 51. Report UW. US World Report rankings of pain management at major hospitals in the United States. Available online at:

    52. 52. Lansky D., Nwachukwu B.U., and Bozic K.J.: Using financial incentives to improve value in orthopaedics. Clin Orthop Relat Res 2012; 470: pp. 1027-1037

    53. 53. So J.P., and Wright J.G.: The use of three strategies to improve quality of care at a national level. Clin Orthop Relat Res 2012; 470: pp. 1006-1016

    Only gold members can continue reading. Log In or Register to continue

    Feb 23, 2017 | Posted by in ORTHOPEDIC | Comments Off on Liposomal Bupivacaine

    Full access? Get Clinical Tree

    Get Clinical Tree app for offline access